Research updates from 4D and C4X

DRUG discovery pioneers C4X and 4D Pharma have delivered positive news to shareholders regarding their product pipelines.

The Manchester-based firms, which both listed on the AIM market last year, said they were nearing the clinical trails phase for some of their prospects.

C4X Discovery Holdings said it had selected a drug candidate from its Orexin-1 programme to enter pre-clinical development prior to the initiation of clinical studies for the treatment of stress-related addictive disorders. This represents ... For the full story register now for free or login below...

Close